Search

everythinglearnresearchcommunity

for

Search:↓

Alopecia in animals can be hereditary, congenital, or acquired, with treatments and outcomes varying widely.

Both finasteride and drospirenone effectively manage PCOS symptoms, but drospirenone is more effective in reducing ovarian volume and androgen levels.

A 5 mg dose of transdermal testosterone cream effectively restores testosterone levels in postmenopausal women.

The IRS-2 Asp/Asp genotype may increase the risk of PCOS in Chinese women, especially if they are not obese.

Obesity may contribute to female hair loss by increasing male hormone levels that affect hair follicles.

Aleglitazar and its major metabolite are safe enough to proceed to Phase 3 clinical trials.

Pharmacists play a crucial role in improving patient outcomes through personalized care and staying updated with scientific advancements.

Telogen Effluvium (TE) significantly affects women due to stress and hormonal changes, requiring better public health policies and mental health support.

Doctors vary in how they initially test for PCOS, but most agree on using oral contraceptives and lifestyle changes as first treatments.

Higher levels of unbound testosterone are linked to increased insulin resistance, especially in women with polycystic ovary syndrome.

5α-reductase inhibitors can cause sexual problems, higher risk of aggressive prostate cancer, and depression.

Prolactin affects the production of different keratins in human hair, which could lead to new treatments for skin and hair disorders.

Post-finasteride patients show changed neuroactive steroid levels, possibly causing erectile dysfunction and depression.

The method safely and efficiently delivers genes to the skin but may not work for conditions needing high levels of gene products.

Cantú syndrome may be linked to pituitary adenomas.

Gene therapy shows promise for enhancing physical traits but faces ethical, safety, and regulatory challenges.

Cholesterol transport in hair follicles decreases from growth to regression phase.

Vitamin D receptor helps control hair growth genes in skin cells.

Oral isotretinoin for severe acne can change hormone levels but does not significantly affect ovarian function.

Finasteride reduces melanin production, possibly treating hyperpigmentation and melanoma, but needs more safety research.

Current research explores hair growth drugs, while future research aims for personalized treatments.

MK-386 and finasteride together effectively reduce DHT levels, potentially treating acne and male pattern baldness.

5α-reductase inhibitors help treat disorders caused by DHT and have potential for future therapies.

Hormone therapy increases facial and body hair in transgender men, while hair removal improves well-being in transgender women, but cost is a barrier as insurance often doesn't cover it. Dermatologists can use various treatments for these hair issues.

The research provides a gene-based framework for hair biology, highlighting the Hippo pathway's importance and suggesting links between hair disorders, cancer pathways, and the immune system.

Disrupted cysteine metabolism may cause hair breakage in Alopecia Areata, suggesting potential treatments like N-acetylcysteine.

Hormonal changes and psychological issues can cause sexual dysfunction in postmenopausal women. Behavioral therapy is recommended first, with hormone replacement helping some symptoms but not libido. Testosterone can improve libido, but its effects on overall sexual function are unclear. Emotional and relationship issues should be addressed before using medication, and the benefits and risks of testosterone supplementation should be considered.

Better hair loss models needed for research.

Neurosteroids like neuro-estrogen and neuro-androgen are crucial for brain function and can improve cognition and protect against aging-related decline.

The dog improved significantly after treatment and needs lifelong thyroid medication.